Efficacy and safety of a 4|week course of repeated subcutaneous ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

This study provides evidence that racemic ketamine, given by subcutaneous injection at adequate doses, is safe and efficacious in the therapy of treatment- ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Ketamine was well tolerated. Acute adverse effects (psychotomimetic, blood pressure increases) resolved within 2 h. Conclusions Adequately dosed subcutaneous ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Ketamine was well tolerated. Acute adverse effects (psychotomimetic, blood pressure increases) resolved within 2 h. Conclusions Adequately dosed ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

PDF | On Oct 14, 2024, Colleen Loo and others published Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections ...

Efficacy and Safety of Subcutaneous Ketamine Injections for ...

Furthermore, the benefits were seen to extend beyond the 4-week treatment course, often lasting weeks and even months in some individuals.

Efficacy and safety of a 4-week course of repeated subcutaneous ...

The study found that ketamine was more efficacious than midazolam (1.75mg/70kg) in the flexible-dose cohort (remission rate 19.6% vs 2.0%), ...

Corrigendum : Efficacy and safety of a 4-week course of repeated ...

Corrigendum : Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Authors: Colleen Loo, Nick Glozier, David Barton, Bernhard T Baune, Natalie T Mills, Paul Fitzgerald, Paul Glue, Shanthi Sarma, Veronica Galvez-Ortiz, ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Conclusions: Adequately dosed subcutaneous racemic ketamine was efficacious and safe in treating TRD over a 4-week treatment period. The subcutaneous route is ...

Efficacy and Safety of Repeated Subcutaneous Ketamine Injections ...

To assess the acute efficacy and safety of a 4-week course of subcutaneous racemic ketamine in participants with TRD. Trial registration ...

Efficacy and safety of a 4-week course of repeated ... - Altmetric

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind ...

Phase 3 Study Finds Subcutaneous Ketamine Safe and Effective in ...

Loo C, Glozier N, Barton D, et al. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant ...

Repeated subcutaneous esketamine on treatment-resistant ...

Promising Response Rates: Reported significant partial response, response, and remission rates at the end of the 8-week treatment period, with ...

Repeated subcutaneous racemic ketamine in treatment-resistant ...

As per the protocol, treatments were stopped once remission was achieved with some clinical leeway up to the maximum of six treatments. None of the patients ...

Ketamine SQ Effective for Treatment-Resistant Depression

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): ...

Double-Blind Trial Shows Low-Cost Subcutaneous Version of ...

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): ...

Repeated doses of subcutaneous esketamine in patients with ...

... week. In some cases, based on the ... repeated administration, with good tolerability and safety. ... efficacy and safety of this therapy on a larger scale.

Impact of Repeated Doses of Subcutaneous Esketamine on Acute ...

Conclusions: Our results suggest that repeated subcutaneous esketamine doses are safe and well-tolerated regarding their acute dissociative and psychotomimetic ...